{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:08:53Z","timestamp":1785863333132,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00404-014-3317-2","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T12:47:44Z","timestamp":1403614064000},"page":"1023-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome"],"prefix":"10.1007","volume":"290","author":[{"given":"Angela","family":"K\u00f6ninger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Edimiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Enekwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Nagarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kasimir-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Strowitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"issue":"6","key":"3317_CR1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745\u20132749","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3317_CR2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","volume":"51","author":"KF Michelmore","year":"1999","unstructured":"Michelmore KF, Balen AH, Dunger DB, Vessey MP (1999) Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 51(6):779\u2013786","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"3317_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41\u201347","journal-title":"Hum Reprod"},{"issue":"12","key":"3317_CR4","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","volume":"88","author":"P Pigny","year":"2003","unstructured":"Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D (2003) Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88(12):5957\u20135962","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3317_CR5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Dewailly D (2006) Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941\u2013945","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"3317_CR6","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S (2011) Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 26(11):3123\u20133129","journal-title":"Hum Reprod"},{"issue":"2","key":"3317_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","volume":"10","author":"S Jonard","year":"2004","unstructured":"Jonard S, Dewailly D (2004) The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10(2):107\u2013117","journal-title":"Hum Reprod Update"},{"issue":"2","key":"3317_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","volume":"18","author":"R Fanchin","year":"2003","unstructured":"Fanchin R, Schon\u00e4uer LM, Righini C, Guibourdenche J, Frydman R, Taieb J (2003) Serum Anti-M\u00fcllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18(2):323\u2013327","journal-title":"Hum Reprod"},{"issue":"3","key":"3317_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1242\/dev.114.3.721","volume":"114","author":"N Clemente di","year":"1992","unstructured":"di Clemente N, Ghaffari S, Pepinsky RB, Pieau C, Josso N, Cate RL, Vigier B (1992) A quantitative and interspecific test for biological activity of anti-m\u00fcllerian hormone: the fetal ovary aromatase assay. Development 114(3):721\u2013727","journal-title":"Development"},{"issue":"2","key":"3317_CR10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1530\/EJE-10-1179","volume":"165","author":"B Wetzka","year":"2011","unstructured":"Wetzka B, Textor W, Ochsner A, Geisth\u00f6vel F (2011) Anti-Mullerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome. Eur J Endocrinol 165(2):323\u2013330","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"3317_CR11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","volume":"59","author":"HY Woo","year":"2012","unstructured":"Woo HY, Kim KH, Rhee EJ, Park H, Lee MK (2012) Differences of the association of anti-M\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J 59(9):781\u2013790","journal-title":"Endocr J"},{"issue":"11","key":"3317_CR12","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","volume":"24","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I (2009) The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 24(11):2917\u20132923","journal-title":"Hum Reprod"},{"issue":"2","key":"3317_CR13","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","volume":"296","author":"A Piouka","year":"2009","unstructured":"Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D (2009) Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 296(2):E238\u2013E243","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"3317_CR14","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A (2010) Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-M\u00fcllerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metab 95(9):4399\u20134405","journal-title":"J Clin Endocrinol Metab"},{"key":"3317_CR15","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","volume":"98","author":"S Iliodromiti","year":"2013","unstructured":"Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM (2013) Can Anti-Mullerian Hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab 98:3332\u20133340","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3317_CR16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","volume":"29","author":"Y Li","year":"2012","unstructured":"Li Y, Ma Y, Chen X, Wang W, Li Y, Zhang Q, Yang D (2012) Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism. J Assist Reprod Genet 29(10):1147\u20131151","journal-title":"J Assist Reprod Genet"},{"key":"3317_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"3317_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijgo.2008.03.017","volume":"102","author":"M Jensterle","year":"2008","unstructured":"Jensterle M, Weber M, Pfeifer M, Prezelj J, Pfutzner A, Janez A (2008) Assessment of insulin resistance in young women with polycystic ovary syndrome. Int J Gynaecol Obstet 102:137\u2013140","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"3317_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"Balen AH, Laven JS, Tan SL, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9(6):505\u2013514","journal-title":"Hum Reprod Update"},{"issue":"5","key":"3317_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jclinepi.2005.09.007","volume":"59","author":"CM Norris","year":"2006","unstructured":"Norris CM, Ghali WA, Saunders LD, Brant R, Galbraith D, Faris P, Knudtson ML, Investigators APPROACH (2006) Ordinal regression model and the linear regression model were superior to the logistic regression models. J Clin Epidemiol 59(5):448\u2013456","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3317_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0900900101","volume":"9","author":"M Pepe","year":"2009","unstructured":"Pepe M, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. Stata J 9(1):1","journal-title":"Stata J"},{"key":"3317_CR22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335","journal-title":"Cancer"},{"key":"3317_CR23","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria ISBN 3-900051-07-0, URL: http:\/\/www.R-project.org\/"},{"issue":"10","key":"3317_CR24","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2013-2193","volume":"98","author":"A Mahran","year":"2013","unstructured":"Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA (2013) The predictive value of circulating anti-mullerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study. J Clin Endocrinol Metab 98(10):4170\u20134175","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3317_CR25","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/humrep\/deu050","volume":"29","author":"X Han","year":"2014","unstructured":"Han X, McShane M, Sahertian R, White C, Ledger W (2014) Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay. Hum Reprod 29(5):1042\u20131048","journal-title":"Hum Reprod"},{"issue":"11","key":"3317_CR26","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF (2006) Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237\u20134245","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3317-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-014-3317-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3317-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:04:53Z","timestamp":1649480693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-014-3317-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["3317"],"URL":"https:\/\/doi.org\/10.1007\/s00404-014-3317-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}